Pricing Log in Create free account

ADC Therapeutics SA (ADCT) vs Alector, Inc. (ALEC)

ADC Therapeutics SA and Alector, Inc. are both Biotechnology companies. Alector, Inc. is the larger, with a market value of $213.3M against $190.2M — 1.1× the size. ADC Therapeutics SA grew revenue faster over the last twelve months: 3.03% against −82.9%. ADC Therapeutics SA has the higher net margin (−121.8% vs −850.1%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, ADC Therapeutics SA leads on 13 and Alector, Inc. on 3.

Valuation

Metric ADCT ALEC Biotechnology median
P/E n/m n/m 8.42
P/S 2.90 15.32 10.01
P/B n/m n/m 2.21
Price to free cash flow n/m n/m 21.01
EV/EBITDA n/m n/m 0.61
EV/Sales 1.61 4.17 9.41
Earnings yield (44.30%) (57.59%) (31.85%)
Free cash flow yield (44.04%) (74.56%) (24.58%)

Profitability

Metric ADCT ALEC Biotechnology median
Gross margin 88.86% 100.00% 65.16%
Operating margin (125.08%) (912.40%) 0.00%
Net margin (121.77%) (850.13%) 0.00%
Free cash flow margin (127.72%) (1,142.55%) 0.00%
Return on equity 45.35% (385.11%) (56.36%)
Return on assets (32.25%) (42.15%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ADCT ALEC Biotechnology median
Revenue growth (TTM) 3.03% (82.91%) 6.02%
EPS growth (last fiscal year) 30.86% (13.01%) 30.26%
Revenue growth, 5-year CAGR 103.35% (0.05%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ADCT ALEC Biotechnology median
Debt to equity (0.51) (0.99) 0.00
Current ratio 3.03 5.26 4.72
Net debt to EBITDA 1.22 1.61 0.96

Dividend

Metric ADCT ALEC Biotechnology median
Dividend yield — — 0.08%
Payout ratio — — —

Size

Metric ADCT ALEC Biotechnology median
Market cap 190.23m 213.27m 132.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack